Compound Detail
CHEMBL350221
OXITRIPTAN 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL350221 |
| Name | OXITRIPTAN |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | LDCYZAJDBXYCGN-VIFPVBQESA-N |
| Therapeutic | ✓ Yes |
7
Targets
12
Activities
2
Assay Types
0
PK Parameters
20
Publications
24
Known Names
5
Indications
Molecular Properties
220.2
MW (Da)
0.83
ALogP
3
HBA
4
HBD
99.3
PSA (Ų)
0.62
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Depressive Disorder Sleep Wake Disorders Depressive Disorder, Major Obesity Spinal Cord Injuries
ATC Classification
N06AX01
oxitriptan
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
EC50 8 meas. best 9.74
Ki 4 meas. best 9.04
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 2C CHEMBL225 | EC50 | 9.74 | 9.7 | 0.2 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 9.04 | 8.89 | 0.9 | 2 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | EC50 | 9.0 | 8.945 | 1.0 | 2 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | EC50 | 8.87 | 8.16 | 1.3 | 3 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 8.67 | 8.67 | 2.1 | 1 |
| 5-hydroxytryptamine receptor 4 CHEMBL4317 | EC50 | 8.01 | 8.01 | 9.8 | 1 |
| Serotonin 3 (5-HT3) receptor CHEMBL2094116 | Ki | 6.8 | 6.8 | 158.5 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 25815143 | 10.1021/ml500385d | Indoleamine 2,3-dioxygenase 1 | 5 |
| 38888620 | 10.1021/acs.jnatprod.4c00118 | Staphylococcus aureus | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 26704965 | 10.1021/acs.jmedchem.5b01153 | 5-hydroxytryptamine receptor 2A | 2 |
| 26704965 | 10.1021/acs.jmedchem.5b01153 | 5-hydroxytryptamine receptor 2B | 2 |
| 26704965 | 10.1021/acs.jmedchem.5b01153 | 5-hydroxytryptamine receptor 2C | 2 |
| 25815143 | 10.1021/ml500385d | Tryptophan 2,3-dioxygenase | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 2 |
| 19113967 | 10.1021/np800501m | Tryprostatin B synthase ftmPT1 | 2 |
| 19113967 | 10.1021/np800501m | Unchecked | 2 |
| - | 10.1016/S0960-894X(01)81243-9 | 5-hydroxytryptamine receptor 4 | 2 |
| 26227779 | 10.1016/j.bmcl.2015.07.030 | 5-hydroxytryptamine receptor 2A | 1 |
| 38888620 | 10.1021/acs.jnatprod.4c00118 | Enterococcus faecium | 1 |
| 25759032 | 10.1016/j.bmcl.2015.02.042 | 5-hydroxytryptamine receptor 7 | 1 |
| 25759032 | 10.1016/j.bmcl.2015.02.042 | 5-hydroxytryptamine receptor 1A | 1 |
| 17417631 | 10.1038/nchembio873 | Unchecked | 1 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
Data from ChEMBL 36 via Core Engine